Merck's R&D chief Perlmutter fails to ignite hope for new drugs
This article was originally published in Scrip
Executive Summary
Merck & Co.’s new R&D chief Roger Perlmutter had a chance to excite his company’s investor base on a quarterly earnings call with analysts, but the exec’s comments weren’t assuring.